Precision BioSciences, Inc.
DTIL
$5.05
$0.091.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.00K | 29.00K | 638.00K | 576.00K | 49.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.00K | 29.00K | 638.00K | 576.00K | 49.90M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 18.00K | 29.00K | 638.00K | 576.00K | 49.90M |
| SG&A Expenses | 9.93M | 9.33M | 7.96M | 9.30M | 9.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.90M | 22.14M | 25.48M | 21.85M | 25.75M |
| Operating Income | -21.88M | -22.11M | -24.85M | -21.28M | 24.15M |
| Income Before Tax | -23.52M | -20.57M | -17.75M | -16.43M | 32.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.52M | -20.57M | -17.75M | -16.43M | 32.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.52M | -20.57M | -17.75M | -16.43M | 32.75M |
| EBIT | -21.88M | -22.11M | -24.85M | -21.28M | 24.15M |
| EBITDA | -21.50M | -21.72M | -24.39M | -20.56M | 25.24M |
| EPS Basic | -2.13 | -2.21 | -2.22 | -2.25 | 4.70 |
| Normalized Basic EPS | -1.33 | -1.39 | -1.32 | -1.46 | 2.96 |
| EPS Diluted | -2.13 | -2.21 | -2.22 | -2.25 | 4.67 |
| Normalized Diluted EPS | -1.33 | -1.39 | -1.32 | -1.46 | 2.94 |
| Average Basic Shares Outstanding | 11.05M | 9.29M | 8.00M | 7.29M | 6.97M |
| Average Diluted Shares Outstanding | 11.05M | 9.29M | 8.00M | 7.29M | 7.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |